Mutation, cell kinetics, and subpopulations at risk for colon cancer in the United States

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 400, Issue 1-2, 1998, Pages 553-578

  Herrero Jimeneza, P ^a   Thilly, G ^b   Southam, P J ^c   Tomita Mitchell, A ^a   Morgenthaler, S ^d   Furth, E E ^e   Thilly, W G ^a  

^a Massachusetts Institute of Technology   (United States)

^b EVERGREEN STATE COLLEGE   (United States)

^c Governor Dummer Academy   (United States)

^d Ecl Polytech Federal de Lausanne ^*  (Switzerland)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epidemiology; Human; Model; Neoplasm

Indexed keywords

ARTICLE; CANCER RISK; CELL KINETICS; COLON CANCER; GENE MUTATION; GENETIC RISK; HUMAN; MATHEMATICAL MODEL; POPULATION RISK; PRIORITY JOURNAL; UNITED STATES;

ADENOMA; APOPTOSIS; CELL CYCLE; CELL DIVISION; COLONIC NEOPLASMS; COMPUTER SIMULATION; DISEASE PROGRESSION; GENETICS, POPULATION; HUMANS; MODELS, STATISTICAL; MUTATION; RISK ASSESSMENT; SURVIVAL RATE; TISSUE SURVIVAL;

EID: 0032565556     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00067-0     Document Type: Article

References (36)

1. [1] W.O. Kermack, A.G. McKendrick, P.L. McKinlay, Death-rates in Great Britain and Sweden: expression of specific mortality rates as products of two factors, and some consequences thereof, J. Hyg. 34 (4) (1934) 433-457.
2. [2] E.L. Kennaway, Cancer of the penis and circumcision in relation to the incubation period of cancer, Br. J. Cancer 1 (4) (1947) 335.
3. [3] C.O. Nordling, A new theory on the cancer-inducing mechanism, Br. J. Cancer 7 (1953) 68-72.
4. [4] P. Armitage, R. Doll, The age distribution of cancer and a multistage theory of carcinogenesis, Br. J. Cancer 8 (1) (1954) 1-12.
5. [5] R. Platt, Lancet i (1955) 867, [letter to the editor].
6. [6] P. Armitage, R. Doll, A two-stage theory of carcinogenesis in relation to the age distribution of human cancer, Br. J. Cancer 9 (2) (1957) 161-169.
7. [7] P.J. Cook, R. Doll, S.A. Fillingham, A mathematical model for the age distribution of cancer in man, Int. J. Cancer 4 (1) (1969) 93-112.
8. [8] R. Peto, Epidemiology, Multistage Models, and Short-term Mutagenicity Tests, Origins of Human Cancer, Cold Spring Harbor Laboratory Cold Spring Harbor, NY, 1977, pp. 1403-1429.
9. [9] R. Peto, F.J. Roe, P.N. Lee, L. Levy, J. Clack, Cancer and ageing in mice and men, Br. J. Cancer 32 (4) (1975) 411-426.
10. [10] A.G. Knudson Jr., Mutation and cancer: Statistical study of retinoblastoma, Proc. Natl. Acad. Sci. U.S.A. 68 (4) (1971) 820-823.
11. [11] S.H. Moolgavkar, D.J. Venzon, Two-event models for carcinogenesis: incidence curves for childhood and adult tumors, Math. Biosci. 47 (1979) 55-77.
12. [12] S.H. Moolgavkar, A.G. Knudson Jr., Mutation and cancer: a model for human carcinogenesis, JNCI 66 (6) (1981) 1037-1052.
13. [13] S.H. Moolgavkar, A. Dewanji, D.J. Venzon, A stochastic two-stage model for cancer risk assessment: I. The hazard function and the probability of tumor, Risk Anal. 8 (3) (1988) 383-392.
14. [14] S.H. Moolgavkar, E.G. Luebeck, Two-event model for carcinogenesis: biological, mathematical, and statistical considerations, Risk Anal. 10 (2) (1990) 323-341.
15. [15] S.H. Moolgavkar, A Population Perspective on Multistage Carcinogenesis, Multistage Carcinogenesis, Japan Sci. Soc. Press, Tokyo/CRC Press, Boca Raton, FL, 1992, pp. 381-391.
16. [16] A. Dewanji, S.H. Moolgavkar, E.G. Luebeck, Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions, Math. Biosci. 104 (1) (1991) 97-109.
17. [17] A. Dewanji, D.J. Venzon, S.H. Moolgavkar, A stochastic two-stage model for cancer risk assessment: II. The number and size of premalignant clones, Risk Anal. 9 (2) (1989) 179-187.
18. [18] J. Jen, S.M. Powell, N. Papadopoulos, K.J. Smith, S.R. Hamilton, B. Vogelstein, K.W. Kinzler, Molecular determinants of dysplasia in colorectal lesions, Cancer Res. 54 (21) (1994) 5523-5526.
19. [19] S.M. Powell, N. Zilz, Y. Beazer-Barclay, T.M. Bryan, S.R. Hamilton, S.N. Thibodeau, B. Vogelstein, K.W. Kinzler, APC mutations occur early during colorectal tumorigenesis, Nature 359 (6392) (1992) 235-237.
20. [20] D. Levy, K.J. Smith, Y. Beazer-Barclay, S.R. Hamilton, B. Vogelstein, K.W. Kinzler, Inactivation of both APC alleles in human and mouse tumors, Cancer Res. 54 (22) (1994) 5953-5958.
21. [21] S.H. Moolgavkar, E.G. Luebeck, Multistage carcinogenesis: population-based model for colon cancer, JNCI 84 (8) (1992) 610-618.
22. [22] T. Hitotsumatsu, T. Iwaki, T. Kitamoto, M. Mizoguchi, S.O. Suzuki, Y. Hamada, M. Fukui, J. Tateishi, Expression of neurofibromatosis 2 protein in human brain tumors: an immunohistochemical study, Acta Neuropathol. (Berl.) 93 (3) (1997) 225-232.
23. [23] U.S. Department of Health and Human Services, Vital Statistics of the United States, Volume II - Mortality Part A, US Government Printing Office, Hyattsvile, MD, 1937-1992.
24. [24] U.S. Bureau of the Census, Mortality Statistics, Special Reports, Washington Government Printing Office, 1900-1936.
25. [25] A.I. Yashin, K.G. Manton, M.A. Woodbury, E. Stallard, The effects of health histories on stochastic process models of aging and mortality, J. Math. Biol. 34 (1) (1995) 1-16.
26. [26] U.S. Department of Health and Human Services, SEER Cancer Statistics Review: 1973-1990, National Cancer Institute, NIH Pub. No. 93-2789, 1993.
27. [27] C.E. Dukes, H.J.P. Bussey, The spread of rectal cancer and its effect on prognosis, Br. J. Cancer 12 (1958) 309.
28. [28] M. Bjerknes, H. Cheng, K. Hay, S. Gallinger, APC mutation and the crypt cycle in murine and human intestine, Am. J. Pathol. 150 (3) (1997) 833-839.
29. [29] W.W. Kinzler, B. Vogelstein, Lessons from hereditary colon cancer, Cell 87 (1996) 159-170.
30. [30] S.H. Moolgavkar, E.G. Luebeck, M. de Gunst, R.E. Port, M. Schwarz, Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiment: I. Single-agent regimen, Carcinogenesis 11 (8) (1990) 1271-1278.
31. [31] S.M. Ross, Introduction to Probability Models, Academic Press, San Diego, 1993, 183-186.
32. [32] P.V. Hamill, T.A. Drizd, C.L. Johnson, R.B. Reed, A.F. Roche, W.M. Moore, Physical growth: National Center for Health Statistics percentiles, Am. J. Clin. Nutr. 32 (3) (1979) 607-629.
33. [33] S.A. Grist, M. McCarron, A. Kutlaca, D.R. Turner, A.A. Morley, In vivo human somatic mutation: frequency and spectrum with age, Mutat. Res. 266 (2) (1992) 189-196.
34. [34] C.C. Harris, M. Hollstein, Clinical implications of the p53 tumor-suppressor gene, New Engl. J. Med. 329 (1993) 1318-1327.
35. [35] W.W. Kinzler, B. Vogelstein, Gatekeepers and caretakers, Nature 386 (1997) 761-763.
36. [36] E. Giovannucci, B. Goldin, The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer, Am. J. Clin. Nutr. 66 (1997) 1564S-1571S, Suppl. 6.